• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于头颈部鳞状细胞癌预后的血管生成相关基因特征的构建与评估

Construction and assessment of an angiogenesis-related gene signature for prognosis of head and neck squamous cell carcinoma.

作者信息

Wang Kaiqin, Zhang Ruizhe, Li Changya, Chen Huarong, Lu Jiafeng, Zhao Houyu, Zhuo Xianlu

机构信息

Department of Otolaryngology, The Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China.

Department of Otolaryngology, Anshun People's Hospital, Anshun, Guizhou, China.

出版信息

Discov Oncol. 2024 Jul 16;15(1):284. doi: 10.1007/s12672-024-01084-z.

DOI:10.1007/s12672-024-01084-z
PMID:39012409
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11252106/
Abstract

OBJECTIVE

Angiogenesis-associated genes (AAGs) play a critical role in cancer patient survival. However, there are insufficient reports on the prognostic value of AAGs in head and neck squamous cell carcinoma (HNSC). Therefore, this study aimed to investigate the correlation between AAG expression levels and survival in HNSC patients, explore the predictive value of signature genes and lay the groundwork for future in-depth research.

METHODS

Relevant data for HNSC were obtained from the databases. AAGs-associated signature genes linked to prognosis were screened to construct a predictive model. Further analysis was conducted to determine the functional correlation of the signature genes.

RESULTS

The signature genes (STC1, SERPINA5, APP, OLR1, and PDGFA) were used to construct prognostic models. Patients were divided into high-risk and low-risk groups based on the calculated risk scores. Survival analysis showed that patients in the high-risk group had a significantly lower overall survival than those in the low-risk group (P < 0.05). Therefore, this prognostic model was an independent prognostic factor for predicting HNSC. In addition, patients in the low-risk group were more sensitive to multiple anti-cancer drugs. Functional correlation analysis showed a good correlation between the characteristic genes and HNSC metastasis, invasion, and angiogenesis.

CONCLUSION

This study established a new prognostic model for AAGs and may guide the selection of therapeutic agents for HNSC. These genes have important functions in the tumor microenvironment; it also provides a valuable resource for the future clinical trials investigating the relationship between HNSC and AAGs.

摘要

目的

血管生成相关基因(AAGs)在癌症患者生存中起关键作用。然而,关于AAGs在头颈部鳞状细胞癌(HNSC)中的预后价值报道不足。因此,本研究旨在探讨HNSC患者中AAG表达水平与生存之间的相关性,探索特征基因的预测价值,并为未来的深入研究奠定基础。

方法

从数据库中获取HNSC的相关数据。筛选与预后相关的AAGs特征基因以构建预测模型。进行进一步分析以确定特征基因的功能相关性。

结果

使用特征基因(STC1、SERPINA5、APP、OLR1和PDGFA)构建预后模型。根据计算出的风险评分将患者分为高风险组和低风险组。生存分析表明,高风险组患者的总生存期明显低于低风险组(P < 0.05)。因此,该预后模型是预测HNSC的独立预后因素。此外,低风险组患者对多种抗癌药物更敏感。功能相关性分析表明特征基因与HNSC转移、侵袭和血管生成之间具有良好的相关性。

结论

本研究建立了一种新的AAGs预后模型,可能指导HNSC治疗药物的选择。这些基因在肿瘤微环境中具有重要功能;它还为未来研究HNSC与AAGs之间关系的临床试验提供了有价值的资源。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d93/11252106/01bad4e80028/12672_2024_1084_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d93/11252106/fdcbbbe3442a/12672_2024_1084_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d93/11252106/607cf78e0fec/12672_2024_1084_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d93/11252106/a53352413ce3/12672_2024_1084_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d93/11252106/bd5a4fbbbdf6/12672_2024_1084_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d93/11252106/610157615e13/12672_2024_1084_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d93/11252106/9b8e4d57c657/12672_2024_1084_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d93/11252106/b899dae6e528/12672_2024_1084_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d93/11252106/01bad4e80028/12672_2024_1084_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d93/11252106/fdcbbbe3442a/12672_2024_1084_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d93/11252106/607cf78e0fec/12672_2024_1084_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d93/11252106/a53352413ce3/12672_2024_1084_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d93/11252106/bd5a4fbbbdf6/12672_2024_1084_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d93/11252106/610157615e13/12672_2024_1084_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d93/11252106/9b8e4d57c657/12672_2024_1084_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d93/11252106/b899dae6e528/12672_2024_1084_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d93/11252106/01bad4e80028/12672_2024_1084_Fig8_HTML.jpg

相似文献

1
Construction and assessment of an angiogenesis-related gene signature for prognosis of head and neck squamous cell carcinoma.用于头颈部鳞状细胞癌预后的血管生成相关基因特征的构建与评估
Discov Oncol. 2024 Jul 16;15(1):284. doi: 10.1007/s12672-024-01084-z.
2
An angiogenesis-associated gene-based signature predicting prognosis and immunotherapy efficacy of head and neck squamous cell carcinoma patients.一个与血管生成相关的基因特征,可预测头颈部鳞状细胞癌患者的预后和免疫治疗疗效。
J Cancer Res Clin Oncol. 2024 Feb 12;150(2):91. doi: 10.1007/s00432-024-05606-8.
3
Cuproptosis-Related lncRNAs are Biomarkers of Prognosis and Immune Microenvironment in Head and Neck Squamous Cell Carcinoma.铜死亡相关长链非编码RNA是头颈部鳞状细胞癌预后和免疫微环境的生物标志物。
Front Genet. 2022 Jul 22;13:947551. doi: 10.3389/fgene.2022.947551. eCollection 2022.
4
Natural killer cell-based signature: Prognostic analysis in head and neck squamous cell carcinoma.基于自然杀伤细胞的特征:头颈部鳞状细胞癌的预后分析。
J Gene Med. 2024 Feb;26(2):e3671. doi: 10.1002/jgm.3671.
5
Construction of the prognostic signature of alternative splicing revealed the prognostic predictor and immune microenvironment in head and neck squamous cell carcinoma.可变剪接预后特征的构建揭示了头颈部鳞状细胞癌的预后预测指标和免疫微环境。
Front Genet. 2022 Oct 21;13:989081. doi: 10.3389/fgene.2022.989081. eCollection 2022.
6
Integrated analysis of diagnostic, prognostic value and potential drug treatment of GSDME in head and neck squamous cell carcinoma.头颈部鳞状细胞癌中 GSDME 的诊断、预后价值及潜在药物治疗的综合分析。
Eur Arch Otorhinolaryngol. 2023 Sep;280(9):4239-4253. doi: 10.1007/s00405-023-08022-9. Epub 2023 May 19.
7
Constructing a prognostic model for head and neck squamous cell carcinoma based on glucose metabolism related genes.基于葡萄糖代谢相关基因构建头颈部鳞状细胞癌预后模型。
Front Endocrinol (Lausanne). 2023 Oct 9;14:1245629. doi: 10.3389/fendo.2023.1245629. eCollection 2023.
8
Identification of an individualized therapy prognostic signature for head and neck squamous cell carcinoma.鉴定头颈部鳞状细胞癌个体化治疗预后特征。
BMC Genomics. 2023 Apr 28;24(1):221. doi: 10.1186/s12864-023-09325-1.
9
Establishment of an immune-related gene prognostic model for head and neck tumors.建立头颈部肿瘤免疫相关基因预后模型。
J Biol Regul Homeost Agents. 2021 May-Jun;35(3):975-986. doi: 10.23812/21-14-A.
10
Peroxisome proliferator-activated receptors signature reveal the head and neck squamous cell carcinoma energy metabolism phenotype and clinical outcome.过氧化物酶体增殖物激活受体特征揭示了头颈部鳞状细胞癌的能量代谢表型和临床结局。
J Gene Med. 2024 Jan;26(1):e3605. doi: 10.1002/jgm.3605. Epub 2023 Nov 6.

引用本文的文献

1
The association between diabetes and head and neck squamous cell carcinoma: evidence from clinical cohort and bioinformatics analyses.糖尿病与头颈部鳞状细胞癌之间的关联:来自临床队列和生物信息学分析的证据。
Front Genet. 2025 Aug 13;16:1660012. doi: 10.3389/fgene.2025.1660012. eCollection 2025.

本文引用的文献

1
Sangerbox: A comprehensive, interaction-friendly clinical bioinformatics analysis platform.Sangerbox:一个全面的、用户交互友好的临床生物信息学分析平台。
Imeta. 2022 Jul 8;1(3):e36. doi: 10.1002/imt2.36. eCollection 2022 Sep.
2
CircRNA-miRNA-VEGFA: an important pathway to regulate cancer pathogenesis.环状RNA-微小RNA-血管内皮生长因子A:调节癌症发病机制的重要途径。
Front Pharmacol. 2023 May 10;14:1049742. doi: 10.3389/fphar.2023.1049742. eCollection 2023.
3
VCAN Hypomethylation and Expression as Predictive Biomarkers of Drug Sensitivity in Upper Urinary Tract Urothelial Carcinoma.
VCAN 低甲基化和表达可作为上尿路上皮癌药物敏感性的预测生物标志物。
Int J Mol Sci. 2023 Apr 19;24(8):7486. doi: 10.3390/ijms24087486.
4
Expression of gene on tumor-associated macrophages of head and neck squamous cell carcinoma, and its correlation with clinical outcome.头颈部鳞状细胞癌肿瘤相关巨噬细胞中 基因的表达及其与临床结局的相关性。
Oncoimmunology. 2023 Apr 18;12(1):2203073. doi: 10.1080/2162402X.2023.2203073. eCollection 2023.
5
Joint effect of THBS2 and VCAN accelerating the poor prognosis of gastric cancer.THBS2 和 VCAN 的共同作用加速了胃癌的不良预后。
Aging (Albany NY). 2023 Feb 13;15(5):1343-1357. doi: 10.18632/aging.204520.
6
Identification and validation of a novel angiogenesis-related gene signature for predicting prognosis in gastric adenocarcinoma.一种用于预测胃腺癌预后的新型血管生成相关基因特征的鉴定与验证
Front Oncol. 2023 Jan 16;12:965102. doi: 10.3389/fonc.2022.965102. eCollection 2022.
7
Angiogenesis-related gene signatures reveal the prognosis of cervical cancer based on single cell sequencing and co-expression network analysis.基于单细胞测序和共表达网络分析的血管生成相关基因特征揭示宫颈癌预后
Front Cell Dev Biol. 2023 Jan 12;10:1086835. doi: 10.3389/fcell.2022.1086835. eCollection 2022.
8
GSCA: an integrated platform for gene set cancer analysis at genomic, pharmacogenomic and immunogenomic levels.GSCA:一个用于在基因组、药物基因组学和免疫基因组学水平进行基因集癌症分析的综合平台。
Brief Bioinform. 2023 Jan 19;24(1). doi: 10.1093/bib/bbac558.
9
TISCH2: expanded datasets and new tools for single-cell transcriptome analyses of the tumor microenvironment.TISCH2:用于肿瘤微环境单细胞转录组分析的扩展数据集和新工具。
Nucleic Acids Res. 2023 Jan 6;51(D1):D1425-D1431. doi: 10.1093/nar/gkac959.
10
Construction and validation of an angiogenesis-related gene expression signature associated with clinical outcome and tumor immune microenvironment in glioma.与胶质瘤临床结局和肿瘤免疫微环境相关的血管生成相关基因表达特征的构建与验证
Front Genet. 2022 Aug 11;13:934683. doi: 10.3389/fgene.2022.934683. eCollection 2022.